5-hydroxyindole levels in rat brain after inhibition of dopamine  -hydroxylase.
D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D001923:Brain Chemistry; D002940:Circadian Rhythm; D004221:Disulfiram / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D006897:Hydroxyindoleacetic Acid / Q000032:analysis*; D007274:Injections, Intraperitoneal; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D007470:Monoiodotyrosine / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000032:analysis* / Q000096:biosynthesis; D013844:Thiazoles / Q000008:administration & dosage / Q000494:pharmacology; D013890:Thiourea / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D008781:Methyltyrosines; D013844:Thiazoles; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D010293:Pargyline; D006899:Mixed Function Oxygenases; D004299:Dopamine beta-Hydroxylase; D007470:Monoiodotyrosine; D013890:Thiourea; D004221:Disulfiram; D009638:Norepinephrine